Full-Time

Global Clinical Affairs Device Specialist

Hybrid

Confirmed live in the last 24 hours

Insulet Corporation

Insulet Corporation

1,001-5,000 employees

Biotechnology
Healthcare

Compensation Overview

$74k - $111.2kAnnually

Junior, Mid

Acton, MA, USA

Requires on-site work from an Insulet office at least 1x/week.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Inventory Management
Requirements
  • Bachelor’s degree and/or an equivalent combination of education or experience.
  • Minimum of 2-5 years of relevant experience in the field.
  • Must have analytical skills, be detail-oriented, and have good interpersonal skills.
  • Knowledge of agency guidelines and requirements.
Responsibilities
  • Collaborate with manager to identify and manage device builds based on study design and regulatory requirements
  • Calculate number of devices needed based on study design
  • Responsible to manage device build timelines to ensure devices are available on time according to overall project plan
  • Coordinate cross-functionally with regulatory, quality, and operations to identify and support appropriate labeling of devices
  • Collaborate with manager to determine device shipping and logistics based on domestic and international requirements
  • Responsible to manage device projections, inventory and site allocations
  • Responsible to manage internal device inventory
  • Collaborate with manager to establish processes and manage appropriate device deficiency and adverse event reporting for pre-market and post-market studies Responsible to manage all device-related vendor relationships
  • Collaborate with manager to identify and manage device needs with partners both internal and external to Insulet
  • Performs other duties as required.

Company Stage

IPO

Total Funding

$134.6M

Headquarters

Acton, Massachusetts

Founded

N/A

Growth & Insights
Headcount

6 month growth

9%

1 year growth

19%

2 year growth

38%
Simplify Jobs

Simplify's Take

What believers are saying

  • The full market release of the Omnipod 5 App for iPhone in the U.S. positions Insulet to capture a significant share of the mobile health market.
  • Significant investments from firms like Baillie Gifford & Co. reflect strong confidence in Insulet's growth potential and market leadership.
  • The new manufacturing facility in Malaysia is expected to create over 1,000 jobs, indicating robust operational expansion and economic impact.

What critics are saying

  • The competitive landscape in insulin delivery technology could challenge Insulet's market position if innovation slows.
  • The integration of new technologies like the G7 and Libre 2 Plus sensors requires seamless execution to avoid potential technical setbacks.

What makes Insulet Corporation unique

  • Insulet Corporation is a global leader in tubeless insulin pump technology, setting it apart from traditional insulin delivery methods.
  • The Omnipod 5's integration with the Freestyle Libre 2 Plus sensor offers a unique real-time glucose monitoring solution, enhancing user experience.
  • Insulet's strategic expansion with a new manufacturing facility in Malaysia demonstrates its commitment to scaling production and meeting global demand.

Help us improve and share your feedback! Did you find this helpful?